| MICU | ||
---|---|---|---|
Pre-intervention (26Â weeks) | Intervention (26Â weeks) | p-value | |
No. of patients | 259 | 242 | Â |
Age, years, median (IQR), | 74 (62–81) | 73 (57–81) | 0.146d |
Male, n (%) | 155 (59.8) | 140 (57.9) | 0.650e |
APACHE II score, median (IQR) | 18 (13–23) | 24 (16–32) | < 0.001d |
VRE rectal carriage on ICU admission, n (%) | 17 (6.6) | 11 (4.5) | 0.326e |
Receipt of surgery, n (%) | 95 (36.7) | 81 (33.5) | 0.452e |
Length of MICU stay, days, median (IQR) | 13 (11–15) | 13 (11–15) | 0.723d |
Length of hospital stay, days, median (IQR) | 25 (17–49) | 24 (14–45) | 0.699d |
In-hospital mortality, n (%) | 98 (37.8) | 77 (31.8) | 0.158e |
Device utilization ratioa | |||
 Mechanical ventilator | 0.50 | 0.63 | < 0.001e |
 Urinary catheter | 0.97 | 0.93 | 0.226e |
 Central venous catheter | 0.64 | 0.63 | 0.927e |
Device-related infectionsb | |||
 CLA-BSI | 1.25 | 1.28 | 0.983e |
 CA-UTI, n (%) | 1.95 | 2.40 | 0.781e |
VRE acquisition rate by weekly active surveillance culturec | |||
 Rectal VRE | 20.17 | 9.34 | < 0.001e |
MDRO incidence rate by clinical culturesc | |||
 VRE | 5.11 | 1.60 | 0.006e |
 MRSA | 5.11 | 7.74 | 0.104e |
 CRAB | 11.02 | 11.20 | 0.850e |